{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:37:01Z","timestamp":1791599821729,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbr.2013.12.045","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T05:15:13Z","timestamp":1389071713000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy"],"prefix":"10.1016","volume":"262","author":[{"given":"Sara Lena","family":"Weinhold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareen","family":"Seeck-Hirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Hallschmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"G\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Christian","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.12.045_bib0005","series-title":"International Classification of Sleep Disorders, Second Edition (ICSD-2): Diagnostic and Coding Manual","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.bbr.2013.12.045_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/sleep\/9.1.232","article-title":"Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia","volume":"9","author":"Baker","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0015","first-page":"73","article-title":"Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption","volume":"13","author":"Montplaisir","year":"1978","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.12.045_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.smrv.2007.08.010","article-title":"Nocturnal aspects of narcolepsy with cataplexy","volume":"12","author":"Plazzi","year":"2008","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.bbr.2013.12.045_bib0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/155005948301400306","article-title":"Narcolepsy and disturbed nocturnal sleep","volume":"14","author":"Wittig","year":"1983","journal-title":"Clin Electroencephalogr"},{"key":"10.1016\/j.bbr.2013.12.045_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1479-8425.2011.00503.x","article-title":"Wake\u2013REM sleep transitions for measuring REM sleep disturbance: comparison between narcolepsy, idiopathic hypersomnia and healthy controls","volume":"9","author":"Weinhold","year":"2011","journal-title":"Sleep Biol Rhythms"},{"key":"10.1016\/j.bbr.2013.12.045_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/smrv.2001.0157","article-title":"Cognitive dysfunction in sleep disorders","volume":"5","author":"Fulda","year":"2001","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.bbr.2013.12.045_bib0040","first-page":"36","article-title":"Attention deficits in patients with narcolepsy","volume":"26","author":"Rieger","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2013.12.045_bib0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2013.12.045_bib0060","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2013.12.045_bib0065","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1460-9568.2000.00919.x","article-title":"The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats","volume":"12","author":"Piper","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2005.04.064","article-title":"Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats","volume":"1048","author":"Akanmu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.12.045_bib0080","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1523\/JNEUROSCI.20-20-07760.2000","article-title":"Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons","volume":"20","author":"Bourgin","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0085","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","article-title":"Fos expression in orexin neurons varies with behavioral state","volume":"21","author":"Estabrooke","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2005.04.035","article-title":"Behavioral correlates of activity in identified hypocretin\/orexin neurons","volume":"46","author":"Mileykovskiy","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2013.12.045_bib0095","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ncomms2461","article-title":"Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction","volume":"4","author":"Blouin","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bbr.2013.12.045_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2013.12.045_bib0105","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1523\/JNEUROSCI.21-18-07273.2001","article-title":"Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat","volume":"21","author":"Gerashchenko","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2013.12.045_bib0115","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2013.12.045_bib0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2013.12.045_bib0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/sleep\/30.8.969","article-title":"CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway","volume":"30","author":"Heier","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/sleep\/33.2.169","article-title":"Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population","volume":"33","author":"Knudsen","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0140","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol (Chicago)"},{"key":"10.1016\/j.bbr.2013.12.045_bib0145","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1073\/pnas.181330998","article-title":"Arousal effect of orexin A depends on activation of the histaminergic system","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0150","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0196-9781(02)00109-2","article-title":"Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats","volume":"23","author":"Kodama","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2013.12.045_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2013.12.045_bib0160","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1523\/JNEUROSCI.0586-04.2004","article-title":"Behavioral state instability in orexin knock-out mice","volume":"24","author":"Mochizuki","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0165","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0166-2236(00)02002-6","article-title":"The sleep switch: hypothalamic control of sleep and wakefulness","volume":"24","author":"Saper","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0170","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.sleep.2011.06.015","article-title":"Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy","volume":"12","author":"Baier","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.bbr.2013.12.045_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/sleep\/4.1.83","article-title":"Sensitivity of the stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping","volume":"4","author":"Herscovitch","year":"1981","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","article-title":"The development and use of the Standford sleepiness scale (SSS)","volume":"10","author":"Hoddes","year":"1973","journal-title":"Psychophysiology"},{"key":"10.1016\/j.bbr.2013.12.045_bib0185","first-page":"97","article-title":"A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms","volume":"4","author":"Horne","year":"1976","journal-title":"Int J Chronobiol"},{"key":"10.1016\/j.bbr.2013.12.045_bib0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2869.1994.tb00104.x","article-title":"The Ullanlinna narcolepsy scale: validation of a measure of symptoms in the narcoleptic syndrome","volume":"3","author":"Hublin","year":"1994","journal-title":"J Sleep Res"},{"key":"10.1016\/j.bbr.2013.12.045_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2013.12.045_bib0200","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0013-4694(97)00010-2","article-title":"A normative study of the maintenance of wakefulness test (MWT)","volume":"103","author":"Doghramji","year":"1997","journal-title":"Electroen Clin Neuro"},{"key":"10.1016\/j.bbr.2013.12.045_bib0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/sleep\/15.3.268","article-title":"The clinical use of the multiple sleep latency test. The standards of practice committee of the American sleep disorders association","volume":"15","author":"Thorpy","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0210","series-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications","author":"Iber","year":"2007"},{"key":"10.1016\/j.bbr.2013.12.045_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1439-054x.2000.00116.x","article-title":"Vigilance, tendency to fall asleep, sustained attention, tiredness, sleepiness diagnostic tools for the measurement of sleepiness related processes and their criteria of quality","volume":"4","author":"Wee\u00df","year":"2000","journal-title":"Somnologie"},{"key":"10.1016\/j.bbr.2013.12.045_bib0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbr.2012.09.015","article-title":"Intracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleep","volume":"237","author":"Kummangal","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2013.12.045_bib0225","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awn193","article-title":"Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal orexin A (hypocretin-1)","volume":"131","author":"Baier","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2013.12.045_bib0230","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0235","first-page":"23","article-title":"Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs","volume":"3","author":"John","year":"2000","journal-title":"Sleep Res"},{"key":"10.1016\/j.bbr.2013.12.045_bib0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0245","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.bbr.2013.12.045_bib0250","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","article-title":"Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog","volume":"26","author":"Fujiki","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2013.12.045_bib0255","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bbr.2013.12.045_bib0260","first-page":"4","article-title":"Intranasal administration of hypocretin 1 (orexin A) bypasses the blood-brain barrier & targets the brain: a new strategy for the treatment of narcolepsy","author":"Hanson","year":"2004","journal-title":"Drug Deliv"},{"key":"10.1016\/j.bbr.2013.12.045_bib0265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.sleep.2007.05.006","article-title":"Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy\/cataplexy","volume":"9","author":"Mattarozzi","year":"2008","journal-title":"Sleep Med Rev"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813007948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813007948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T18:57:24Z","timestamp":1565031444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813007948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":53,"alternative-id":["S0166432813007948"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.12.045","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}